secwatch / observer
8-K filed June 8, 2026, 9:19 AM ET ticker FICO CIK 0000814547
other material confidence high sentiment positive materiality 0.75

FAIR ISAAC CORP (FICO): debt financing — FICO borrows $1.5B, authorizes $2B buyback, launches $1.5B ASR

FAIR ISAAC CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

FAIR ISAAC CORP incurred term loan of $1.5 billion with Wells Fargo Bank, National Association at Daily Simple SOFR plus an applicable margin maturing May 15, 2028.

Instrument
term loan
Principal
$1.5 billion
Counterparty
Wells Fargo Bank, National Association
Rate
Daily Simple SOFR plus an applicable margin
Maturity
May 15, 2028
Event
incurrence
Exact text from the filing
Agreement”). The First Amendment provides for an unsecured incremental term loan under the Credit Agreement that will mature on May 15, 2028 in the aggregate principal amount of $1.5 billion (the “Incremental Term Loan”) and makes certain other changes to the Existing Credit Agreement. The Company borrowed the full amount of the Incremental Term Loan on June 5, 2026,
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FAIR ISAAC CORP amended First Amendment with Wells Fargo Bank, National Association valued at $1.5 billion (effective 2026-06-05).

Action
amendment
Agreement
credit facility
Counterparty
Wells Fargo Bank, National Association
Value
$1.5 billion
Effective
2026-06-05
Exact text from the filing
On June 5, 2026, Fair Isaac Corporation (the “Company”) entered into an amendment (the “First Amendment”) to its Third Amended and Restated Credit Agreement
View on SEC.gov

289 debt financings filed in the last 30 days. Browse all debt financings →

FAIR ISAAC CORP filing history →

Source: SEC EDGAR
accession 0001193125-26-260817
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.